Home » Topics » BioWorld Science

BioWorld Science
RSS

Neurex's SNX-111 progresses through clinical trials

Aug. 9, 1996

NMPA and/or AMPA antagonists from Warner-Lambert

Aug. 9, 1996

Sandoz's Exelon shows positive results in phase III

Aug. 9, 1996

NMDA antagonists claimed by E. Merck

Aug. 9, 1996

Dainippon's new compound superior to metoclopramide for digestive function improvement

Aug. 9, 1996

Teva's Copaxone progresses toward FDA approval

Aug. 9, 1996

Health-Mark Diagnostics is now wholly owned by TCPI

Aug. 9, 1996

Resource Biometrics acquired by IBAH

Aug. 9, 1996

Gelman Sciences and Memtec to merge

Aug. 9, 1996

Apotex acquires Protein S.A. de C.V.

Aug. 9, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 31, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 2, 2026.
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
AND-017 increases RBC and hemoglobin in sickle cell disease
BioWorld Science
Sickle cell disease (SCD) is an inherited hemoglobinopathy caused by a mutation in the gene encoding β-globin that results in hemoglobin S polymerization, red...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...